EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 160 filers reported holding EPIZYME INC in Q2 2020. The put-call ratio across all filers is 0.16 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $65,000 | -85.8% | 25,990 | -12.1% | 0.00% | -100.0% |
| Q1 2020 | $458,000 | -94.5% | 29,557 | -95.5% | 0.01% | -91.9% |
| Q3 2015 | $8,391,000 | -59.4% | 652,472 | -24.3% | 0.06% | -51.2% |
| Q2 2015 | $20,679,000 | +119.3% | 861,627 | +71.6% | 0.13% | +67.1% |
| Q1 2015 | $9,428,000 | – | 502,031 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
| Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
| KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
| Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
| Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
| MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
| Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
| Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
| Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
| Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |